Unique ID issued by UMIN | UMIN000022575 |
---|---|
Receipt number | R000025908 |
Scientific Title | Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease |
Date of disclosure of the study information | 2016/06/02 |
Last modified on | 2019/05/20 13:37:00 |
Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease
Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease
Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease
Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease
Japan |
Ulcerative colitis,Crohn disease
Gastroenterology |
Others
NO
Efficacy of oral Qing-Dai in patients with inflammatory bowel disease
Safety
Confirmatory
Pragmatic
The rate of clinical remission at 4 weeks
1)The rate of clinical response and mucosal healing at 4 weeks
2)The rate of maintaining clinical remission,clinical response and mucosal healing at 52 weeks
3)Side effects of oral Qing-Dai
4)The changes of mucosal miRNA,microbiota,and inflammatory cytokines
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
Patients take oral Qing-Dai in capsule form twice a day(daily dose,2g)for 4 weeks.If patients achieve clinical remission or show clinical response,they will be allowed to continue taking these drugs for 52 weeks.
16 | years-old | <= |
Not applicable |
Male and Female
1)Patients who have moderate to severe active ulcerative colitis(Left-sided or Extensive type,CAI=>6) or Crohn disease(CDAI=>220)
2)Adult patients
3)Patients with no change in treatment within the past 2 weeks before the commencement of the study
4)Patients who have never been treated with Qing-Dai
5)Patients who have received adequate information regarding this study and understood throughly,and then voluntarily submitted written consent forms upon participation in this study
1)Pregnant or breastfeeding women
2)Patients who have a history of psychosomatic disorders
3)Patients who have a history of liver or renal diseases
4)Patients who have a history of antithrombotic therapy or thrombocytopenia
5)Patients who have a history of hepatitis B
6)Patients whom investigators and subinvestigators considered inappropriate to participate in this study
60
1st name | Takanari |
Middle name | |
Last name | Kitazono |
Graduate School of Medical Sciences,Kyushu University
Department of Medicine and Clinical Science
812-8582
Maidashi 3-1-1,Higashi-ku,Fukuoka
092-642-5261
kitazono@intmed2.med.kyushu-u.ac.jp
1st name | Atsushi |
Middle name | |
Last name | Hirano |
Graduate School of Medical Sciences,Kyushu University
Department of Medicine and Clinical Science
812-8582
Maidashi 3-1-1,Higashi-ku,Fukuoka
092-642-5261
http://www.gut.med.kyushu-u.ac.jp/news/detail/?id=9
atsuhira@intmed2.med.kyushu-u.ac.jp
Kyushu University
Kyushu University
Other
KYUSHU UNIVERSITY Center for Clinical and Translational Research(CCTR)
3-1-1 Maidashi, Higashi-ku
092-642-5774
byskenkyu@jimu.kyushu-u.ac.jp
NO
九州大学病院
2016 | Year | 06 | Month | 02 | Day |
Unpublished
33
Completed
2016 | Year | 06 | Month | 02 | Day |
2016 | Year | 05 | Month | 24 | Day |
2016 | Year | 06 | Month | 02 | Day |
2019 | Year | 03 | Month | 29 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2016 | Year | 06 | Month | 01 | Day |
2019 | Year | 05 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025908
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |